Tesla secures a Buy rating with an $364.24 price target driven by energy storage, Robotaxis, and Optimus robotics. Despite recent margin compression from heavy AI and R&D spending, massive growth in …
JP Morgan upgraded Tesla to Neutral from Underweight, significantly raising its price target to $475. Analyst Rajat Gupta highlights the underappreciated value of Tesla's hardware-software integratio…
Tesla shares rose 2.8% after the Delaware Supreme Court upheld Elon Musk's 2018 compensation plan, removing legal uncertainty. Positive catalysts include testing of fully driverless vehicles, plans f…
Tesla shares rose 3.8% following Wedbush's $600 price target highlighting 2026 as a pivotal year driven by AI and driverless tech advances. Despite volatility and a cautious Morgan Stanley downgrade,…
Piper Sandler reaffirmed a $500 price target on Tesla after testing its Full Self-Driving v14, praising its performance and robo-taxi demo. Tesla's autonomous tech progress and recent regulatory appr…
Tesla shares rose over 5% after a price target hike, despite a 40% profit drop, driven by optimism in energy, self-driving tech, and CEO pay incentives tied to ambitious growth goals.
Tesla shares rose 5.2% after Cantor Fitzgerald raised its price target to $510, citing production milestones and growth in Energy and Full Self-Driving segments, supported by positive US-China trade …
J.P. Morgan raised Tesla's PT to $150 from $115 after upbeat Q3 deliveries but keeps a cautious view, noting limited sustainable growth; market median PT is $341 and shares trade above those targets.
Canaccord raised Tesla's price target to $490 citing strong Q3 deliveries, new vehicle launches, energy growth and AI progress, implying roughly 10% upside from the last close.
Tesla shares rose ~3.5% on AI and robotics optimism and analyst price-target hikes, including Wedbush's $600 target; a new class-action securities lawsuit was also filed alleging fraud between April …
Tesla shares rose after analysts raised price targets, citing AI initiatives, robotaxi and humanoid robotics optimism, supported by a European sales rebound despite earlier declines.